TY - JOUR
T1 - Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk
T2 - results from ADVANCE
AU - You, Shoujiang
AU - Zheng, Danni
AU - Wang, Yanan
AU - Li, Qiang
AU - Nguyen, Tu N.
AU - Peters, Ruth
AU - Chen, Xiaoying
AU - Wang, Xia
AU - Cao, Yongjun
AU - Grobbee, Diederick E.
AU - Harrap, Stephen
AU - Mancia, Giuseppe
AU - Williams, Bryan
AU - Poulter, Neil R.
AU - Lisheng, Liu
AU - Marre, Michel
AU - Hamet, Pavel
AU - Anderson, Craig S.
AU - Woodward, Mark
AU - Chalmers, John
AU - Harris, Katie
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/2/12
Y1 - 2025/2/12
N2 - Background: To explore whether healthy lifestyle factors (HLFs) predict a lower risk of major macrovascular and microvascular events and death in people with type 2 diabetes (T2D) with a high risk of vascular complications. Methods: Post hoc analyses of 11,133 participants with T2D in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial who were assigned a score ranging from 0 to 4 based on the number of baseline HLFs: never smoked, moderate-to-vigorous physical activity, ideal waist/hip ratio, and low-to-moderate alcohol consumption. Multivariable Cox models were used to determine associations of 0, 1, 2, and ≥ 3 HLFs with vascular events and all-cause mortality. Results: Compared to participants with no HLFs, hazard ratios for participants with 3 or 4 HLFs were 0.68 (95% confidence interval [CI] 0.57–0.81) for the composite of major macrovascular or microvascular events, 0.58 (0.46–0.75) for major macrovascular events, 0.78 (0.61–0.99) for microvascular events, and 0.48 (0.37–0.63) for all-cause mortality during a median follow-up of 5 years. Each increment in HLF score was significantly associated with lower rates of these outcomes. There was no heterogeneity in the effect on any outcome by HLF across randomized intensive blood glucose control and blood pressure lowering treatments. Conclusions: HLFs are associated with lower risks of major macrovascular and microvascular events and lower rates of death in high-risk adults with T2D.
AB - Background: To explore whether healthy lifestyle factors (HLFs) predict a lower risk of major macrovascular and microvascular events and death in people with type 2 diabetes (T2D) with a high risk of vascular complications. Methods: Post hoc analyses of 11,133 participants with T2D in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial who were assigned a score ranging from 0 to 4 based on the number of baseline HLFs: never smoked, moderate-to-vigorous physical activity, ideal waist/hip ratio, and low-to-moderate alcohol consumption. Multivariable Cox models were used to determine associations of 0, 1, 2, and ≥ 3 HLFs with vascular events and all-cause mortality. Results: Compared to participants with no HLFs, hazard ratios for participants with 3 or 4 HLFs were 0.68 (95% confidence interval [CI] 0.57–0.81) for the composite of major macrovascular or microvascular events, 0.58 (0.46–0.75) for major macrovascular events, 0.78 (0.61–0.99) for microvascular events, and 0.48 (0.37–0.63) for all-cause mortality during a median follow-up of 5 years. Each increment in HLF score was significantly associated with lower rates of these outcomes. There was no heterogeneity in the effect on any outcome by HLF across randomized intensive blood glucose control and blood pressure lowering treatments. Conclusions: HLFs are associated with lower risks of major macrovascular and microvascular events and lower rates of death in high-risk adults with T2D.
KW - ADVANCE
KW - Diabetes
KW - Healthy lifestyle factors
KW - Major macrovascular events
KW - Microvascular events
UR - http://www.scopus.com/inward/record.url?scp=85218451434&partnerID=8YFLogxK
U2 - 10.1186/s12916-025-03932-3
DO - 10.1186/s12916-025-03932-3
M3 - Article
AN - SCOPUS:85218451434
SN - 1741-7015
VL - 23
JO - BMC Medicine
JF - BMC Medicine
IS - 1
M1 - 87
ER -